Results for "Novo Nordisk"
Keyword scan across titles, descriptions, summaries, and tags. For interview listings, try Guest appearances.
10 results
Episodes
StandardSummaries onlyNovo Nordisk (Ozempic)
Acquired· Ben Gilbert· Jan 22, 2024
Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became …
investing
StandardSummaries onlyEPS #278 | Building Wealth Together: Our Community Portfolio Review | + Novo Nordisk News, Rio Tinto & Glencore Merger, Terry Smith's Annual Shareholder Letter,
Dividend Talk· Jan 10, 2026
In this episode of the Dividend Talk podcast, we review the performance of their Community Dividend Growth Portfolio, discuss Novo Nordisk's news, the Rio Tinto & Glencore Merger, Terry Smiths Fundsmith annual shareholde…
investing
StandardSummaries onlyEPS #269 | Novo Nordisk Earnings, Kimberly-Clark Buys Kenvue, & Our Update on monthly dividend portfolio
Dividend Talk· Nov 8, 2025
In this week’s episode of Dividend Talk we kick off with Kimberly-Clark’s surprise move to buy Kenvue, asking if it’s a smart acquisition or a future balance-sheet headache. Then we review Q3 earnings from Novo Nordisk, …
aiinvesting
Intelligent ReportAnthropic's IPO Play, Novo Nordisk x OpenAI, and the First Brain Sensor Goes Human
The Jaeden Schafer Podcast· Apr 15, 2026
Zuckerberg's AI clone, Apple's smart glasses, Vercel's IPO readiness, Anthropic drama, banks testing a dangerous AI model, and a Molotov cocktail attack on Sam Altman's home.
openaianthropic
StandardSummaries onlyEps 262 | 4 Reliable Dividend Stocks for September 2025
Dividend Talk· Sep 5, 2025
Derek and Edgi share four safe dividend stocks for September ,Accenture, Fuchs Petrolub, Canadian Natural Resources, and Munich Re. They also cover market news on Sanofi, Novo Nordisk, and T. Rowe Price, discuss dividend…
investing
StandardSummaries onlyEPS 276| 2025 Year in Review & Crazy Predictions for 2026
Dividend Talk· Dec 26, 2025
We wrap up 2025 with a full Dividend Talk year-in-review, reflecting on the biggest investing lessons, most discussed stocks, and the questions that mattered most to dividend growth investors.In this episode, we cover:• …
investing
StandardSummaries onlyEPS 267 | Q3 Earnings and should we be worried about Evolution Gaming
Dividend Talk· Oct 24, 2025
In this week’s episode of Dividend Talk, we’re back with Q3 Earnings Roundup.We kick things off with Novo Nordisk shaking up half its board of directors, before covering two big dividend announcements from McDonald’s and…
investing
StandardSummaries onlyGrowth Investor Turned Dividend Investor from Heavy Moat Investment| Ep 308
Dividend Talk· Sep 25, 2026
Niklas from Heavy Moat Investments is back. Last time he barely cared about dividends. Now 80% of his portfolio pays one. We talk about how becoming a dad changed the way he looks at risk, why he raised his hurdle rate t…
investing
StandardSummaries onlyHow to Find US & European Dividend Growth Stocks | Insurance Dividend Boom, Novo Nordisk & AI Risks | EPS 285
Dividend Talk· Mar 1, 2026
How do you consistently find high-quality US and European dividend growth stocks? In Episode 285, we revisit our original stock screening framework and update it for today’s market environment including AI disruption, in…
aiinvesting
StandardSummaries onlyEps 264| How We Handle Drawdowns in Dividend Growth Investing
Dividend Talk· Sep 20, 2025
In this episode, we dive into the realities of dealing with portfolio drawdowns as dividend growth investors. From personal examples to strategies for averaging down, price anchoring, and knowing when to hold or sell, we…
investing